|
1
|
Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY,
Lu WG and Xie X: Reduced miR-100 expression in cervical cancer and
precursors and its carcinogenic effect through targeting PLK1
protein. Eur J Cancer. 47:2166–2174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamamoto N, Kinoshita T, Nohata N, Itesako
T, Yoshino H, Enokida H, Nakagawa M, Shozu M and Seki N: Tumor
suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013.PubMed/NCBI
|
|
3
|
Bosch FX, Lorincz A, Muñoz N, Meijer CJ
and Shah KV: The causal relation between human papillomavirus and
cervical cancer. J Clin Pathol. 55:244–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pisani P, Bray F and Parkin DM: Estimates
of the world-wide prevalence of cancer for 25 sites in the adult
population. Int J Cancer. 97:72–81. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McCredie MR, Sharples KJ, Paul C, Baranyai
J, Medley G, Jones RW and Skegg DC: Natural history of cervical
neoplasia and risk of invasive cancer in women with cervical
intraepithelial neoplasia 3: A retrospective cohort study. Lancet
Oncol. 9:425–434. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kato H, Morioka H, Aramaki S and Torigoe
T: Radioimmunoassay for tumor-antigen of human cervical squamous
cell carcinoma. Cell Mol Biol Incl Cyto Enzymol. 25:51–56.
1979.PubMed/NCBI
|
|
7
|
Kato H: Squamous cell carcinoma antigen.
Serological cancer Markers. Sell S: Humana Press. (Totowa).
437–451. 1992. View Article : Google Scholar
|
|
8
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5′UTR as in the 3′UTR. Proc Natl Acad Sci USA. 104:9667–9672. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohyashiki K, Umezu T, Yoshizawa S, Ito Y,
Ohyashiki M, Kawashima H, Tanaka M, Kuroda M and Ohyashiki JH:
Clinical impact of down-regulated plasma miR-92a levels in
non-Hodgkin's lymphoma. PLoS One. 6:e164082011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schrauder MG, Strick R, Schulz-Wendtland
R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A,
Hein A, et al: Circulating micro-RNAs as potential blood-based
markers for early stage breast cancer detection. PLoS One.
7:e297702012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Al-Nedawi K, Meehan B, Micallef J, Lhotak
V, May L, Guha A and Rak J: Intercellular transfer of the oncogenic
receptor EGFRvIII by microvesicles derived from tumour cells. Nat
Cell Biol. 10:619–624. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Allegra A, Alonci A, Campo S, Penna G,
Petrungaro A, Gerace D and Musolino C: Circulating microRNAs: New
biomarkers in diagnosis, prognosis and treatment of cancer
(review). Int J Oncol. 41:1897–1912. 2012.PubMed/NCBI
|
|
20
|
Xu J, Cao Z, Liu W, You L, Zhou L, Wang C,
Lou W, Sun B, Miao Y, Liu X, et al: Plasma miRNAs effectively
distinguish patients with pancreatic cancer from controls: A
multicenter study. Ann Surg Jun. 25:(Epub ahead of print).
2015.
|
|
21
|
Wu J, Ji X, Zhu L, Jiang Q, Wen Z, Xu S,
Shao W, Cai J, Du Q, Zhu Y and Mao J: Up-regulation of
microRNA-1290 impairs cytokinesis and affects the reprogramming of
colon cancer cells. Cancer Lett. 329:155–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Endo Y, Toyama T, Takahashi S, Yoshimoto
N, Iwasa M, Asano T, Fujii Y and Yamashita H: miR-1290 and its
potential targets are associated with characteristics of estrogen
receptor α-positive breast cancer. Endocr Relat Cancer. 20:91–102.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Belian E, Kurucz R, Treue D and Lage H:
Effect of YB-1 on the regulation of microRNA expression in
drug-sensitive and drug-resistant gastric carcinoma cells.
Anticancer Res. 30:629–633. 2010.PubMed/NCBI
|
|
24
|
Wulfken LM, Moritz R, Ohlmann C,
Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel
G, von Ruecker A, Müller SC and Ellinger J: MicroRNAs in renal cell
carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS
One. 6:e257872011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun X, Liu Y, Li M, Wang M and Wang Y:
Involvement of miR-485-5p in hepatocellular carcinoma progression
targeting EMMPRIN. Biomed Pharmacother. 72:58–65. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fawzy IO, Hamza MT, Hosny KA, Esmat G, El
Tayebi HM and Abdelaziz AI: miR-1275: A single microRNA that
targets the three IGF2-mRNA-binding proteins hindering tumor growth
in hepatocellular carcinoma. FEBS Lett. 589:2257–2265. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PLoS One. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takeshita N, Hoshino I, Mori M, Akutsu Y,
Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, et
al: Serum microRNA expression profile: miR-1246 as a novel
diagnostic and prognostic biomarker for oesophageal squamous cell
carcinoma. Br J Cancer. 108:644–652. 2013. View Article : Google Scholar : PubMed/NCBI
|
